Migraine in 68 Markets – Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Reasons to buy the ‘Migraine’ market analysis report:

This report provides:

  • Overview of migraine, including epidemiology, symptoms, diagnosis, and disease management.
  • Annualized migraine therapeutics market revenue, cost of therapy per patient, and treatment usage patterns forecast from 2023 to 2033.
  • Key topics include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping, and implications of these factors for the migraine therapeutics market.
  • Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for migraine treatment. The most promising candidates in late-stage development are profiled.
  • Analysis of the current and future market competition in the global migraine therapeutics market. The report also covers an insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

How is our ‘Migraine in 68 Markets’ report unique from other reports in the market?

  • Design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the 7MM migraine therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 7MM migraine therapeutics market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

We recommend this valuable source of information to anyone involved in:

  • ​​​​Pharma and Biotech Companies – CNS Drug Manufacturers and Suppliers
  • Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)
  • Pharmaceutical Industry Suppliers/Pharma Manufacturers (Innovative, Biotech, Generics, Biosimilars, Rare/Orphan Disease)/Distributors
  • Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)/Parallel Trade Organisations
  • Healthcare Organisations/Healthcare Technology Leaders and Start-ups

To Get a Snapshot of the Migraine in 68 Markets Report

Download a Free Report Sample

Migraine Market in 68M Report Overview

The migraine market size across the 68M was $17.19 billion in 2023. The “Migraine in 68 Markets – Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033” market research report covers the 68 geographical markets and provides an Excel-based forecast model for the migraine market through 2033.

Migraine Market in 68M Outlook, 2023-2033 ($ Billion)

Migraine Market in 68M Outlook, 2023-2033 ($ Billion)

Buy the Full Report for More Insights on the Migraine Market in 68M Report Forecast

Download a Free Report Sample

The report contains sales forecast extrapolations for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) and 61 geographical markets (61M). These extrapolations leverage data on pharmaceutical sales and drug availability from GlobalData’s World Markets Healthcare and POLI Price Intelligence databases.

Market Size (2023) $17.19 Billion
Key Regions ·       Africa

·       APAC

·       Europe

·       LATAM

·       Middle East

·       North America

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Migraine Market in 68M Segmentation by Regions

The geographical regions encompassing the migraine market include Africa, APAC, Europe, LATAM, the Middle East, and North America. In 2023, North America accounted for the highest regional share of the migraine market across 68M.

Migraine Market in 68M Analysis by Regions, 2023 (%)

Migraine Market in 68M Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights on Migraine Market in 68M
Download a Free Report Sample

Segments Covered in the Report

Migraine Market in 68M Regional Outlook (Value, $ Billion, 2023-2033)

  • Africa
  • APAC
  • Europe
  • LATAM
  • Middle East
  • North America
GSK
Dr. Reddy's Laboratories
OptiNose
Currax Pharmaceuticals
Tonix Pharmaceuticals
AstraZeneca
Endo Pharmaceuticals
Almirall
Viatris
Bausch Health Companies
IPI Legacy Liquidation Co
Supernus Pharmaceuticals
Upsher-Smith Laboratories
Sandoz
Merck & Co
Mallinckrodt
AbbVie
Johnson & Johnson
Eli Lilly
Amgen
Teva Pharmaceutical Industries
H. Lundbeck AS
Bristol-Myers Squibb
Axsome Therapeutics
Satsuma Pharmaceuticals
Amneal Pharmaceuticals
Klaria Pharma
Ipsen
Allodynic Therapeutics
Auden McKenzie
Lupin
Orion

Table of Contents

  • About GlobalData
  • List of Contents
  • List of Tables
  • List of Figures
  • 1 Executive Summary

    • 1.1 Overview
    • 1.2 68M summary statistics
    • 1.3 Key 7MM events driving the 68M forecast extrapolation

  • 2 Appendix

    • 2.1 Abbreviations
    • 2.2 Methodology

      • 2.2.1 Patient-based forecast methodology
      • 2.2.2 68M forecast extrapolation methodology.

    • 2.3 Primary research – key opinion leaders interviewed for this report.

      • 2.3.1 Key opinion leaders

    • 2.4 Primary research – prescriber survey
    • 2.5 About the authors

      • 2.5.1 Analyst
      • 2.5.2 Therapy area directors
      • 2.5.3 Epidemiologist
      • 2.5.4 Epidemiology reviewers
      • 2.5.5 Vice President of Disease Intelligence and Epidemiology
      • 2.5.6 Global Head of Pharma Research, Analysis, and Competitive Intelligence

  • 3 Contact Us

Table

Table 1: Disease Migraine: Key Metrics in the 7MM

Table 2: Migraine Classification from the ICHD-3

Table 3: Diagnostic Criteria for Migraine with Aura

Table 4: Diagnostic Criteria for Migraine without Aura

Table 5: Risk Factors and Comorbidities for Migraine

Table 6: Treatment Guidelines for Disease Migraine

Table 7: Most Prescribed Drugs for Migraine by Class in the 7MM

Table 8: Migraine Market – Global Drivers and Barriers, 2020–2030

Table 9: Key Events Impacting Sales for Migraine in the US, 2020–2030

Table 10: Migraine Market – Drivers and Barriers in the US, 2020–2030

Table 11: Key Events Impacting Sales for Migraine in the 5EU, 2020–2030

Table 12: Migraine Market – Drivers and Barriers in the 5EU, 2020-2030

Table 13: Key Events Impacting Sales for Migraine in Japan, 2020–2030

Table 14: Migraine Market – Drivers and Barriers in Japan, 2020– 2030

Table 15: High-Prescribing Physicians (non-KOLs) Surveyed, By Country

Figures

Figure 1: Global Sales Forecast by Country for Migraine in 2020 and 2030

Figure 2: Analysis of the Company Portfolio Gap in Migraine During the Forecast Period

Figure 3: Competitive Assessment of the Marketed and Pipeline Drugs Benchmarked Against the SOC for Acute Migraine Treatment, Imitrex.

Figure 4: Competitive Assessment of the Marketed and Pipeline Drugs Benchmarked Against SOC for Preventive Migraine Treatment, generic propranolol.

Figure 5: Pathophysiology of a Migraine

Figure 6: 7MM, 12-Month Total Prevalence of Migraine, Men and Women, %, Ages ≥18 Years, 2020

Figure 7: 7MM, Sources Used and Not Used to Forecast the 12-Month Total Prevalent Cases of Migraine

Figure 8: 7MM, Sources Used to Forecast the 12-Month Total Prevalent Cases of Migraine by Frequency

Figure 9: 7MM, Sources Used to Forecast the 12-Month Total Prevalent Cases of Migraine by Type

Figure 10: 7MM, Sources Used to Forecast the Diagnosis Rate of Migraine

Figure 11: 7MM, 12-Month Total Prevalent Cases of Migraine, N, Both Sexes, Ages ≥18 Years, 2020

Figure 12: 7MM, 12-Month Total Prevalent Cases of Migraine by Age, N, Both Sexes, 2020

Figure 13: 7MM, 12-Month Total Prevalent Cases of Migraine by Sex, N, Ages ≥18 Years, 2020

Figure 14: 7MM, 12-Month Total Prevalent Cases of Migraine by Frequency, N, Both Sexes, Ages ≥18 Years, 2020

Figure 15: 7MM, 12-Month Total Prevalent Cases of Migraine by Type, N, Both Sexes, Ages ≥18 Years, 2020

Figure 16: 7MM, 12-Month Diagnosed Prevalent Cases of Migraine, N, Both Sexes, Ages ≥18 Years, 2020

Figure 17: Unmet Needs and Opportunities in Migraine

Figure 18: Overview of the Development Pipeline in Migraine

Figure 19: Key Late-Stage Trials for the Promising Pipeline Agents that GlobalData Expects to Be Licensed for Migraine in the 7MM During the Forecast Period

Figure 20: Competitive Assessment of the Marketed and Pipeline Drugs Benchmarked Against the SOC for Acute Migraine Treatment, Imitrex.

Figure 21: Competitive Assessment of the Marketed and Pipeline Drugs Benchmarked Against SOC for Preventive Migraine Treatment, generic propranolol.

Figure 22: Analysis of the Company Portfolio Gap in Migraine During the Forecast Period

Figure 23: Global (7MM) Sales Forecast by Country for Migraine in 2020 and 2030

Figure 24: Global (7MM) Sales Forecast by Drug Class for Migraine in 2020 and 2030

Figure 25: Sales Forecast by Class for Migraine in the US in 2020 and 2030

Figure 26: Sales Forecast by Class for Migraine in the 5EU in 2020 and 2030

Figure 27: Sales Forecast by Class for Migraine in the Japan in 2020 and 2030

Frequently asked questions

Migraine in 68 Markets – Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033 standard reports
Currency USD
$14,995

Can be used by individual purchaser only

$44,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Migraine in 68 Markets – Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Migraine reports
Pharmaceuticals
New
Venture Capital Investment Trends in Pharma - Q2 2026
$795 | July 2026
Pharmaceuticals
New
Merger and Acquisition Trends in Pharma - Q2 2026
$795 | July 2026
Pharmaceuticals
New
Emerging Market Outsourcing Report, Q2 2026
$2,950 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Migraine in 68 Markets – Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033 in real time.

  • Access a live Migraine in 68 Markets – Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.